Top Section/Ad
Top Section/Ad
Most recent
Dasha Sobornova joins from Akin Gump with experience across asset classes
Trade body for levfin investors turns to leading rating analyst
Demand for riskiest tranches and improved loan supply could support growth in issuance
Dana Point 'no longer the end' of the year as market retains momentum
More articles/Ad
More articles/Ad
More articles
-
Last week marked what looks like the death of the Trans-Pacific Partnership (TPP), a comprehensive trade agreement that would have heralded closer integration between the US and the high growth economies of the Asia-Pacific region. -
US CLO market players have quickly moved past the shock result of last week’s presidential election, refocusing on the US risk retention deadline on December 24.
-
European ABS spreads widened briefly on Wednesday morning after the shock US election result, but quickly recovered.
-
US private equity firm Och-Ziff Capital Management closed its first European CLO on Thursday, as pricing of junior CLO debt defies the tightening seen at the top of the capital stack.
-
Valeant Pharmaceuticals, the biggest obligor in US CLOs, is understood to be selling off assets in an attempt to pay down debt. But it may not be the shot in the arm the sector is after, writes Sam Kerr.
-
With aggressive leveraged loan repricing hitting the returns to CLO structures, managers are taking a variety of steps to protect their portfolios.
